TAKTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)

ADRCNew York Stock Exchange (XNYS)·USD

Identity

Security key: 22293
Ticker: TAK
Type: ADRC — American Depository Receipt Common
Exchange: New York Stock Exchange(XNYS)
Venue group: NYSE
Operating MIC: XNYS
Market: stocks
Locale: us
Currency: USD
Listed: 2008-03-07
Round lot: 100
Active: Yes
Last seen in a load: 2026-08-14 20:49
Vendor updated: 2026-08-13 06:09
Ticker root / suffix: TAK

Detail

Enriched 2026-08-14 20:47

Market cap: $55,598,885,105.98
Shares outstanding (class): 3,204,109,718
Shares outstanding (weighted): 3,193,502,878
SIC: —
Employees: 47,029
Location: —
Homepage: https://www.takeda.com
Description: Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.5 trillion in fiscal 2025. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with about 50% from the US, 10% from Japan, 25% from Europe, and 15% from Canada.

Market cap and share counts drift.

Funds holding this security

8 funds · 8 positions · $99.82M reported value, as of 2026-03-31

All holders →

Fund	Ticker	Position value	% of fund	Balance	Match
VanEck Pharmaceutical ETF VanEck ETF Trust	PPH	$40.47M	3.15%	2,185,449 NS	FIGI
First Trust Value Line Dividend Index Fund First Trust Exchange-Traded Fund	FVD	$35.16M	0.43%	1,898,366 NS	FIGI
Amplify CWP International Enhanced Dividend Inc… Amplify ETF Trust	IDVO	$16.42M	1.60%	886,835 NS	FIGI
Catalyst/MAP Global Equity Fund MUTUAL FUND SERIES TRUST	—	$3.13M	3.48%	169,000 NS	FIGI
Mercer Non-US Core Equity Fund Mercer Funds	—	$3.12M	0.07%	168,500 NS	FIGI
Carillon Chartwell Real Income Fund Carillon Series Trust	—	$1.76M	0.65%	95,000 NS	FIGI
Catalyst/MAP Global Balanced Fund MUTUAL FUND SERIES TRUST	—	$426.0K	2.92%	23,000 NS	FIGI
Blackstone Alternative Multi-Strategy Fund Blackstone Alternative Investment Funds	—	-$676.0K	-0.02%	-36,500 NS	FIGI

How positions resolve to the securities master. FIGI_COMPOSITE is exact identifier equality — both sides got the FIGI from Bloomberg. TICKER is a narrow fallback used only where the master row carries no FIGI at all (2,389 rows do not, disproportionately Irish-domiciled US listings like LIN and ACN). Roughly 22% of all positions resolve to the master.

Funds holding this security

Identifiers

master.security_identifier

TICKERTAK
FIGI_COMPOSITEBBG000LF8708
FIGI_SHARE_CLASSBBG001T8N8N0
CIK0001395064
ISINUS8740602052
Resolved through OpenFIGI from a holdings ISIN, not supplied by the securities vendor.

Identifiers

Classification

classification.v_security_classification

Asset class: Equity
Sector: Health Care
Industry: Pharmaceuticals
Source: LLMunreviewed
Self-reported confidence: 0.95
Model: deepseek
Rationale: Takeda is a global pharmaceutical company, so it falls under healthcare and pharmaceuticals.

Classifications are unreviewed model output. All 5,771 assignments carry source = LLM and is_reviewed = false. Confidence is the model’s own estimate and is not calibrated — it clustered at 0.90–0.98 across the whole first pass, including rows that later proved wrong. Use it to order a review queue, not as a probability. Two share classes of one issuer can disagree.

Classification

Fund data

Not linked to a fund series.

Either this is not a fund, or it is one the SEC share-class snapshot cannot reach — commodity trusts and notes have no series ID at all.